Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis From Hepatocellular Carcinoma in Mice

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m116.752519
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Janus Kinase-2 (JAK-2)

Science-Business eXchange
2011English

Fusion of the Genes Ataxin 2 Like, ATXN2L, and Janus Kinase 2, JAK2, in Cutaneous CD4 Positive T-Cell Lymphoma

Oncotarget
Oncology
2017English

Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and P70 Ribosomal S6 Kinase1 (S6K1) Pathways

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

Adipocyte JAK2 Mediates Spontaneous Metabolic Liver Disease and Hepatocellular Carcinoma

JCI insight
Medicine
2019English

A Novel miR-219-SMC4-JAK2/Stat3 Regulatory Pathway in Human Hepatocellular Carcinoma

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Polycythemia in Hepatocellular Carcinoma-Bearing B6C3F1 Mice.

Journal of Toxicologic Pathology
Forensic MedicineToxicologyPathology
1996English

HCV Infection-Associated Hepatocellular Carcinoma in Humanized Mice

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2015English

The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2011English

AIM2 Deficiency Reduces the Development of Hepatocellular Carcinoma in Mice

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy